ask="N/A"
ask_size="N/A"
average_daily_volume="428635"
bid="83.00"
bid_size="200"
book_value="11.49"
change="+3.72"
change_from_200_day_moving_average="15.15"
change_from_50_day_moving_average="9.52"
change_from_52_week_high="-3.24"
change_From_52_week_low="41.59"
change_in_percent="+4.41%"
close="88.11"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-6.21"
ebitda="-244.58M"
eps_estimate_current_year="-7.11"
eps_estimate_next_quarter="-1.78"
eps_estimate_next_year="-6.45"
ex_dividend_date="N/A"
float_shares="38575000"
high="88.59"
high_52_weeks="91.35"
last_trade_date="3/15/2017"
last_trade_price="88.11"
last_trade_size="38080"
last_trade_time="4:00pm"
low="82.53"
low_52_weeks="46.52"
market_capitalization="3.68B"
moving_average_200_day="72.96"
moving_average_50_day="78.59"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="93.71"
open="84.73"
pe_ratio="N/A"
peg_ratio="-0.41"
percent_change_from_200_day_moving_average="+20.77%"
percent_change_from_50_day_moving_average="+12.11%"
percent_change_from_52_week_high="-3.54%"
percent_change_from_52_week_low="+89.40%"
previous_close="84.39"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.34"
price_per_sales="26475.62"
revenue="133000.00"
shares_outstanding="41726000"
short_ratio="11.26"
stock_exchange="NMS"
symbol="RARE"
volume="482937"
weeks_range_52="46.52 - 91.35"
